A new piece of technology is streamlining healthcare pathways for area patients with prostate issues. Memorial Hospital of Sweetwater County now has innovative MRI technology that has completely ...

Innovative AI technologies have the potential to act like a ‘second pair of eyes’, helping radiologists review prostate MRI scans.

Prostate cancer is the second most commonly diagnosed cancer among men worldwide, with an estimated 1.55 million new cases in 2024. 3 MRI helps clinicians assess whether prostate cancer may be present ...

High-resolution microultrasonography-guided biopsy was non-inferior to MRI fusion-guided biopsy for detecting clinically significant prostate cancer (detection rates, 47.1% and 42.6%, respectively), a ...

There are several strategies for the early detection of prostate cancer. The first step is often a blood test for prostate-specific antigen (PSA). If PSA levels exceed a certain threshold, the next ...

In the new guidance, the agency has concluded that AI-Rad Companion Prostate MR, DeepHealth Prostate, ProstatID, Prostate ...

A lack of generalizability in the early days of AI development was one of the biggest caveats attached to the technology.

Profound Medical (NASDAQ:PROF) and Telix Pharmaceuticals (NASDAQ:TLX) have signed a co-education agreement aimed at increasing physician awareness of how advanced diagnostic imaging can support ...

System combines MRI imaging with robotic needle guidance. Asan Medical Center in South Korea has introduced Mona Lisa, a robotic-assisted prostate biopsy system that combines MRI imaging and robotic ...

Aggressive margin reduction with MRI-guided stereotactic body radiotherapy (SBRT) led to a significantly lower incidence of late genitourinary and gastrointestinal toxicities at 2 years compared with ...

Through GE Healthcare's AI Innovation Lab, Mass General Brigham and UW-Madison will pair the company's magnetic resonance imaging foundational model with real data from their hospital systems and then ...

NICE has recommended five AI technologies that can be used in the NHS to help detect prostate cancer on MRI scans.